Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

CGRP MAbs treatment for migraines may also improve rosacea symptoms, but more research is needed to confirm its effectiveness and safety.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Methotrexate plus prednisolone had the fewest serious side effects.

The treatment cleared psoriasis in some patients but caused side effects in most.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Ixekizumab is safe for long-term use with low rates of major heart-related events.

Combining glucocorticoids with immunosuppressants like cyclophosphamide improves remission and reduces relapse in pemphigus patients.

Adalimumab effectively stabilized severe folliculitis decalvans, preventing further hair loss and inflammation.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

Baricitinib works better than methotrexate for severe alopecia areata.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Ocrelizumab may cause total body hair loss in some patients.

Many patients in the rheumatology clinic adjusted or stopped their medications due to side effects.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Acitretin is effective for certain types of psoriasis, safe for long-term use, and often combined with other treatments.

Sacituzumab Tirumotecan shows promise in treating gynecologic cancers with manageable side effects.

An antibiotic called co-trimoxazole can effectively treat autoimmune diseases.

Individualized treatments may help manage Dercum's disease symptoms.

Immune cell-targeting biologics show potential for treating alopecia areata but need better-targeted therapies.

IFNγ-primed MSC secretomes can improve joint health by reducing inflammation and supporting tissue repair.

Ro 10-9359 is an effective treatment for severe psoriasis but can cause side effects.